by ODWAdmin | Oct 1, 2025 | Uncategorized
Antibody-drug conjugate (ADC) resistance represents one of the most formidable challenges in precision oncology, with clinical failures often attributed to our limited understanding of the dynamic molecular mechanisms underlying therapeutic escape. Panome Bio’s...
by Jason Heaviland | Sep 13, 2025 | Uncategorized
Your ELISA confirms the therapeutic enzyme is present. Your Western blot shows a band at the correct molecular weight. But here’s the critical question: is the enzyme actually functional? For mRNA-based enzyme replacement therapies targeting rare metabolic...
by ODWAdmin | Apr 16, 2025
This sample data report characterizes global changes in protein phosphorylation, protein expression, and pathway activity due to reduced KRAS activity. Gain a better understanding of phosphorylation events with Panome Bio’s global phosphoproteomics service...
